Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in
  • Log out

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
  • Log out
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

September 25, 2001; 57 (6) Brief Communications

Quantification of tissue damage in AD using diffusion tensor and magnetization transfer MRI

M. Bozzali, M. Franceschi, A. Falini, S. Pontesilli, M. Cercignani, G. Magnani, G. Scotti, G. Comi, M. Filippi
First published September 25, 2001, DOI: https://doi.org/10.1212/WNL.57.6.1135
M. Bozzali
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Franceschi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Falini
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Pontesilli
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Cercignani
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Magnani
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Scotti
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Comi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Filippi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Quantification of tissue damage in AD using diffusion tensor and magnetization transfer MRI
M. Bozzali, M. Franceschi, A. Falini, S. Pontesilli, M. Cercignani, G. Magnani, G. Scotti, G. Comi, M. Filippi
Neurology Sep 2001, 57 (6) 1135-1137; DOI: 10.1212/WNL.57.6.1135

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
750

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Abstract

The authors measured mean diffusivity (D̄) and magnetization transfer ratio (MTR) of the brain from 18 patients with AD and 16 healthy control subjects. The peak heights of cortical gray matter (cGM) D̄ (p < 0.001) and MTR (p < 0.001) histograms were lower and average cGM D̄ (p < 0.01) higher in patients with AD than in control subjects. A composite MR score based on brain volume and cGM MTR peak height was correlated with patient cognitive impairment (r = 0.65, p = 0.003). This preliminary study presents a novel approach to quantify AD-related tissue damage in-vivo.

MRI studies have shown atrophy of the overall brain or specific brain structures in AD.1-4⇓⇓⇓ Other quantitative MR techniques have also been applied to achieve in vivo estimates of AD-related metabolic or structural changes.4-6⇓⇓ We recently developed an automated technique, based on fractional anisotropy (FA) thresholding, that allows reliable segmentation of brain gray (GM) and white (WM) matter.7 Using this technique, we measured magnetization transfer ratio (MTR) and mean diffusivity (D̄) of large cortical GM (cGM) portions from patients with AD in an attempt to provide a novel approach to quantify AD pathology in vivo.

Patients and methods.

We studied 18 patients (10 women, 8 men; mean age [range], 71.3 [64 to 81] years; median disease duration [range], 24 [12 to 40] months) who met the National Institute of Neurological and Communicative Disorders and Stroke–Alzheimer’s Disease and Related Disorders Association (NINCDS-ADRDA) criteria for clinically probable AD,8 and 16 healthy control subjects (9 women, 7 men; mean age [range], 69.0 [65 to 70] years). Major systemic, psychiatric, and other neurologic illnesses were carefully excluded. Subjects were excluded from the study if they had either one T2-hyperintense area with a diameter ≥5 mm or more than four T2-hyperintense areas smaller than 5 mm. Mean Mini-Mental State Examination (MMSE) score9 (corrected for age and level of education) was 17.7 (range, 5.0 to 25.4) for patients with AD and 27.7 (range, 26.3 to 30.7) for control subjects.

The following MRI sequences were obtained: 1) dual-echo turbo spin echo (SE) (TR = 3300, TE = 16/98, echo train length = 5); 2) T1-weighted SE (TR = 650, TE = 12); 3) 2D gradient-echo (GE) (TR = 640, TE = 12, flip angle = 20°), with and without an off-resonance radio-frequency (RF) saturation pulse (offset frequency = 1.5 kHz, Gaussian envelope duration = 7.68 msec, flip angle = 500°); and 4) pulsed-gradient spin-echo (PGSE) echo-planar (inter-echo spacing = 0.8, TE = 123), with diffusion gradients applied in eight noncollinear directions, chosen to cover three-dimensional space uniformly. Additional information about this sequence is reported elsewhere.7 For the dual-echo, T1-weighted and GE sequences, 24 contiguous, 5 mm-thick axial slices were acquired with an in-plane resolution of approximately 1 × 1 mm. The slices were positioned to run parallel to a line that joins the most inferoanterior and inferoposterior parts of the corpus callosum. For the PGSE scans, 10 5 mm-thick slices were acquired with the same orientation as the other scans, positioning the second-last caudal slice to match exactly the central slices of the other image sets.

Two observers, unaware to whom the scans belonged, identified any white matter hyperintensity on the dual-echo scans. Brain volumes were measured by a single observer, again unaware to whom the scans belonged, using the entire T1-weighted image set of slices and a segmentation technique based on signal intensity thresholding.10 Image postprocessing to obtain MTR, D̄, and FA maps was run as described elsewhere.7 Then, GM and WM were segmented using a technique based on FA thresholding.7 MTR and D̄ characteristics of the brain tissue (BT), cGM, and WM were studied using histogram analysis, as previously described.7 Using standard anatomic landmarks, the imaged portions of the temporal and occipital lobes were segmented on the coregistered T2-weighted images. The selected regions were then superimposed on the GM maps to produce the corresponding MTR and D̄ histograms. For each histogram, we derived the peak height, the peak location, and the average MTR and D̄.

Student’s t-test was used to compare histogram metrics from patients with AD and control subjects. Multivariable linear regression models were used to generate composite MR scores. Each score was computed using a linear combination of MR parameters, chosen on a priori biologic considerations. The weight of each MR parameter resulted from the coefficients estimated by the regression model. The correlations between MMSE and the composite MR scores were evaluated by Spearman correlation analysis. To reflect the large numbers of comparisons, a p value ≤0.01 was considered significant and a p value between >0.01 and ≤0.05 was considered a trend.

Results.

Aspecific WM hyperintense lesions were detected on scans from four controls and five patients with AD. Brain volume was lower (p < 0.001) in patients with AD (mean [SD] = 918 [82] ml) than in control subjects (mean [SD] = 1086 [99] ml). The peak heights of the BT D̄ and MTR histograms were lower and average brain D̄ higher in patients with AD than in control subjects (table 1). The same differences were found when considering cGM (table 2). A significance trend for the cGM D̄ histogram peak location was also found. The peak heights of D̄ and MTR histograms of temporal lobe GM were lower and the peak location of the D̄ histogram higher in patients with AD than in control subjects (table 3). A significance trend was found for temporal lobe average D̄. No significant difference was found between patients with AD and control subjects for any of the histogram-derived measures of the occipital lobe GM. WM average D̄ (0.89 ± 0.05 versus 0.85 ± 0.04 mm2s−1; p = 0.007) and peak height of the D̄ histogram (126.0 ± 22.6 versus 143.9 ± 15.7; p = 0.01) were different between patients and controls.

View this table:
  • View inline
  • View popup
Table 1.

Mean (SD) magnetization transfer ratio (MTR) and mean diffusivity (D̄) histogram-derived metrics of brain tissue from patients with AD and control subjects

View this table:
  • View inline
  • View popup
Table 2.

Mean (SD) magnetization transfer ratio (MTR) and mean diffusivity (D̄) histogram-derived metrics of cortical gray matter from patients with AD and control subjects

View this table:
  • View inline
  • View popup
Table 3.

Mean (SD) magnetization transfer ratio (MTR) and mean diffusivity (D̄) histogram-derived metrics of temporal lobe from patients with AD and control subjects

Two composite MR models were created using quantities reflecting different aspects of AD pathology. The first item was brain volume, which reflects the extent of tissue loss, and the second item was either cGM D̄ histogram peak height or cGM MTR histogram peak height (both these quantities reflect intrinsic pathology of the residual cGM7). The r values of the correlations with the MMSE score were 0.21 for brain volume, 0.31 for cGM D̄ histogram peak height, and 0.58 (p = 0.01) for cGM MTR histogram peak height. The composite MR score derived from the second model (i.e., brain volume and cGM MTR histogram peak height) was strongly correlated with MMSE score (r = 0.65, p = 0.003). The r value of the correlation between the other composite MR score and MMSE score was 0.40.

Discussion.

In this preliminary study based on MTR and D̄ histogram analysis, we showed reduced MTR and increased D̄ in a large brain portion from patients with AD. This is likely to reflect two of the major pathologic events of AD, i.e., nerve cell loss in cGM and Wallerian degeneration of WM fibers. Although information related to the status of specific brain structures is lost, this approach might be desirable in the context of clinical trials of AD, in which it may be unfeasible to measure MR changes from several different regions of the brain.

The definition of MTR and D̄ characteristics of specific brain regions and tissues was achieved by segmenting GM and WM pixels using an automated technique based on a quantitative index of tissue microstructural organization.7 We showed abnormal water distribution and diffusivity in the cGM and in that of the temporal lobe taken in isolation. This is consistent with nerve cell loss in associative cortices of patients with AD. Admittedly, we cannot exclude that, because of brain atrophy, more pixels with partial volume effect from the cerebrospinal fluid might have been introduced in the patients’ GM pool, thus contributing to reduced MTR and increased D̄ values. Although we cannot exclude the presence of selective partial volume averaging, the demonstration that MTR and D̄ of the occipital lobe GM did not differ between patients with AD and control subjects suggests that partial volume averaging is likely not to have affected our results significantly.

Because GM histogram peak heights and brain volume reflect the intrinsic damage and the extent of residual tissue,7 we anticipated that aggregates of these MR measures might result in more accurate pictures of tissue damage in AD than those derived from the application of these MR techniques in isolation. Our results confirmed that, in patients with AD, a composite MR score is strongly related with a clinical measure of overall cognitive function.

Acknowledgments

Supported by the Italian Ministry of Health and the Armenise–Harvard Foundation.

Acknowledgment

The authors thank Dr. M.P. Sormani for help with statistical analysis.

Footnotes

  • Presented at the 53rd annual meeting of the American Academy of Neurology; Philadelphia, PA; May 5–11, 2001.

  • Received February 22, 2001.
  • Accepted May 24, 2001.

References

  1. ↵
    Fox NC, Freeborough PA, Rossor MN. Visualisation and quantification of rates of atrophy in Alzheimer’s disease. Lancet . 1996; 348: 94–97.
    OpenUrlCrossRefPubMed
  2. ↵
    Foundas AL, Leonard CM, Mahoney SM, Agee OF, Heilman KM. Atrophy of the hippocampus, parietal cortex and insula in Alzheimer’s disease: a volumetric magnetic resonance imaging study. Neuropsychiatry Neuropsycol Behav Neurol . 1997; 10: 81–89.
  3. ↵
    Scheltens P. Early diagnosis of dementia: neuroimaging. J Neurol . 1999; 246: 16–20.
    OpenUrlCrossRefPubMed
  4. ↵
    Schuff N, Amend D, Ezekiel F, et al. Changes of hippocampal N-acetyl aspartate and volume in Alzheimer disease. A proton MR spectroscopic imaging and MRI study. Neurology . 1997; 49: 1513–1521.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Meyeroff DJ, MacKay S, Constans JM, et al. Axonal injury and membrane alterations in Alzheimer’s disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol . 1994; 36: 40–47.
    OpenUrlCrossRefPubMed
  6. ↵
    Hanyu H, Shindo H, Kakizaki D, et al. Increased diffusion in cerebral white matter in Alzheimer’s disease. Gerontology . 1997; 43: 343–351.
    OpenUrlPubMed
  7. ↵
    Cercignani M, Bozzali M, Iannucci G, Comi G, Filippi M. Magnetization transfer and mean diffusivity of normal appearing white and grey matter from patients with MS. J Neurol Neurosurg Psychiatry . 2001; 70: 311–317.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    McKhann G, Drachman D, Folstein M, Katzman R, Price D, Standlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology . 1984; 34: 939–944.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Folstein MF, Folstein SE, McHugh PR. Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res . 1975; 12: 189–198.
    OpenUrlCrossRefPubMed
  10. ↵
    Rovaris M, Inglese M, van Schijndel RA, et al. Sensitivity and reproducibility of volume change measurements of different brain portions on magnetic resonance imaging in patients with multiple sclerosis. J Neurol . 2000; 247: 960–965.
    OpenUrlCrossRefPubMed

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Patients and methods.
    • Results.
    • Discussion.
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study

Dr. Robert Shapiro and Dr. Amynah Pradhan

► Watch

Related Articles

  • No related articles found.

Topics Discussed

  • Alzheimer's disease
  • MRI

Alert Me

  • Alert me when eletters are published
Neurology: 100 (5)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise